Interaction effect of blood glucose and pressure on the risk of chronic kidney disease: a population-based prospective cohort study

被引:4
|
作者
Wang, Minzhen [1 ]
Xia, Miao [1 ]
Yang, Hongyan [1 ]
Zhang, Desheng [2 ]
Zhao, Yanan [1 ]
He, Yingqian [1 ]
Liu, Jing [1 ]
Zhang, Lulu [1 ]
Yin, Chun [2 ]
Bai, Yana [1 ]
机构
[1] Lanzhou Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Lanzhou 730000, Gansu, Peoples R China
[2] Workers Hosp Jinchuan Grp Co Ltd, Jinchang 737100, Gansu, Peoples R China
基金
中国国家自然科学基金;
关键词
Blood glucose; Blood pressure; Chronic kidney disease; Prospective cohort study; Interaction; COMMUNITY-BASED POPULATION; TYPE-2; DIABETES-MELLITUS; HYPERTENSION; PREVALENCE; 10-YEAR; IMPACT; INJURY; CKD;
D O I
10.1007/s12020-022-03094-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the interaction effect of blood glucose and blood pressure on the risk of chronic kidney disease (CKD). Methods: 31,165 subjects were selected without CKD at baseline and had completed the first follow-up from "Jinchang cohort". Cox regression model and restricted cubic splines functions were used to evaluate the effects of blood glucose or pressure on the incidence of CKD and dose-response relationship after adjusting for confounding covariates. Synergic effect was assessed by the multiplicative or additive interaction scale. Results: Among 31,165 subjects, 1307 new-onset CKD were observed during 68905.78 person-years follow-up, and the incidence density was 18.97 per 1000 person-years. The risk of CKD gradually increased with the increase of blood pressure in diabetes, pre-diabetes and normal groups (P-trend < 0.05). And, the risk was greatest when SBP/DBP reached >= 150/>= 110 mmHg in three groups, and HRs (95% CI) were 1.610 (1.070-2.422), 2.142 (1.396-3.288) and 2.455 (1.941-3.106), respectively. Additionally, among hypertension, pre-hypertension and normal groups, the risk of CKD increased by 16.0%, 14.3% and 25.2% for each 1 mmol/L of FPG. When FPG level was more than 9.0 mmol/L, the risk was greatest and adjusted HRs (95% CI) were 2.856 (2.176-3.748), 2.979 (1.828-4.854) and 7.520 (4.517-12.519). Furthermore, the risk was highest when hypertension was accompanied by diabetes (HR = 4.915, 95% CI: 3.923-6.157). This analysis supported a less than multiplicative effect (HR = 0.634, 95% CI: 0.417-0.964) for the interaction term of diabetes and hypertension, while there was no additive interaction towards CKD in all interaction term. Conclusions: Blood glucose and pressure were independent risk factors in incidence of CKD, but there was only a negative multiplicative interaction between hypertension and diabetes, but no additive interaction effect between them.
引用
收藏
页码:252 / 261
页数:10
相关论文
共 50 条
  • [21] Dietary cadmium exposure and chronic kidney disease: A population-based prospective cohort study of men and women
    Thomas, Laura D. K.
    Elinder, Carl-Gustaf
    Wolk, Alicja
    Akesson, Agneta
    INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2014, 217 (07) : 720 - 725
  • [22] Functional vitamin K status and risk of incident chronic kidney disease and microalbuminuria: a prospective general population-based cohort study
    Groothof, Dion
    Post, Adrian
    Sotomayor, Camilo G.
    Keyzer, Charlotte A.
    Flores-Guerero, Jose L.
    Hak, Eelko
    Bos, Jens H. J.
    Schurgers, Leon J.
    Navis, Gerjan J.
    Gans, Reinold O. B.
    Eelderink, Coby
    de Borst, Martin H.
    Bakker, Stephan J. L.
    Riphagen, Ineke J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (12) : 2290 - 2299
  • [23] Chronic hepatitis B virus infection and risk of chronic kidney disease: a population-based prospective cohort study of 0.5 million Chinese adults
    Si, Jiahui
    Yu, Canqing
    Guo, Yu
    Bian, Zheng
    Qin, Chenxi
    Yang, Ling
    Chen, Yiping
    Yin, Li
    Li, Hui
    Lan, Jian
    Chen, Junshi
    Chen, Zhengming
    Lv, Jun
    Li, Liming
    BMC MEDICINE, 2018, 16
  • [24] Chronic hepatitis B virus infection and risk of chronic kidney disease: a population-based prospective cohort study of 0.5 million Chinese adults
    Jiahui Si
    Canqing Yu
    Yu Guo
    Zheng Bian
    Chenxi Qin
    Ling Yang
    Yiping Chen
    Li Yin
    Hui Li
    Jian Lan
    Junshi Chen
    Zhengming Chen
    Jun Lv
    Liming Li
    BMC Medicine, 16
  • [25] Risk factors for childhood chronic kidney disease: a population-based study
    Geylis, Michael
    Coreanu, Tara
    Novack, Victor
    Landau, Daniel
    PEDIATRIC NEPHROLOGY, 2023, 38 (05) : 1569 - 1576
  • [26] Obesity, hyperhomocysteinaemia and risk of chronic kidney disease: a population-based study
    Lai, Shih-Han
    Tsai, Yi-Wen
    Chen, Yi-Chuan
    Chang, Shy-Shin
    FAMILY PRACTICE, 2018, 35 (03) : 259 - 265
  • [27] Risk factors for childhood chronic kidney disease: a population-based study
    Michael Geylis
    Tara Coreanu
    Victor Novack
    Daniel Landau
    Pediatric Nephrology, 2023, 38 : 1569 - 1576
  • [28] Periodontal disease and risk of mortality and kidney function decline in advanced chronic kidney disease: a nationwide population-based cohort study
    Tai, Ying-Hsuan
    Chen, Jui-Tai
    Kuo, Hsien-Cheng
    Chang, Wei-Jen
    Wu, Mei-Yi
    Dai, Ying-Xiu
    Liu, Wan-Chi
    Chen, Tzeng-Ji
    Wu, Hsiang-Ling
    Cherng, Yih-Giun
    CLINICAL ORAL INVESTIGATIONS, 2021, 25 (11) : 6259 - 6268
  • [29] Periodontal disease and risk of mortality and kidney function decline in advanced chronic kidney disease: a nationwide population-based cohort study
    Ying-Hsuan Tai
    Jui-Tai Chen
    Hsien-Cheng Kuo
    Wei-Jen Chang
    Mei-Yi Wu
    Ying-Xiu Dai
    Wan-Chi Liu
    Tzeng-Ji Chen
    Hsiang-Ling Wu
    Yih-Giun Cherng
    Clinical Oral Investigations, 2021, 25 : 6259 - 6268
  • [30] Higher potassium intake is associated with a lower risk of chronic kidney disease: population-based prospective study
    Kim, Hyo Jeong
    Koh, Hee Byung
    Heo, Ga Young
    Kim, Hyung Woo
    Park, Jung Tak
    Chang, Tae Ik
    Yoo, Tae-Hyun
    Kang, Shin-Wook
    Kalantar-Zadeh, Kamyar
    Rhee, Connie
    Han, Seung Hyeok
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2024, 119 (04): : 1044 - 1051